Hospital Universitario De Badajoz

At Hospital Universitario De Badajoz, a major share of clinical research focuses on neoplasms, especially breast cancer. Studies span early and advanced disease, including hormone receptor-positive, HER2-positive, and triple-negative subtypes, with the goal of improving treatment effectiveness, reducing recurrence, and refining personalized care.

• Testing new targeted and immunotherapy-based approaches for early and metastatic breast cancer
• Evaluating treatments designed to lower recurrence risk after standard therapy
• Studying biomarker-guided strategies to better match therapy to tumor biology

This oncology program also includes work in metastatic disease and treatment-resistant cancer, reflecting a strong interest in more precise and durable cancer control.

The site’s Nefrology department supports research in chronic kidney disease, kidney transplantation, and urothelial cancer. These trials are aimed at improving kidney health, preventing complications after transplant, and exploring better options for bladder and urinary tract cancers.

• Assessing therapies for chronic kidney disease and transplant-related complications
• Studying treatment options for urothelial carcinoma and related urinary cancers
• Exploring approaches that may improve recovery and long-term kidney outcomes

Research in this area combines renal medicine with cancer care, showing a broad interest in both organ preservation and disease control.

Clinical trials in cardiovascular diseases and metabolism address conditions such as hypertension, acute coronary syndrome, stroke, pulmonary embolism, and spontaneous coronary artery dissection. The main purpose is to improve prevention, reduce complications, and test more effective long-term management strategies.

• Evaluating therapies for high blood pressure and related kidney risk
• Studying treatment approaches for stroke and other acute vascular events
• Investigating ways to lower the risk of recurrent cardiovascular complications

This work highlights a strong focus on cardiorenal health, an area closely connected to the hospital’s nephrology expertise.

Another important part of the research portfolio covers respiratory tract diseases, virus diseases, bacterial infections, and immune system diseases. Trials in this space are studying conditions such as non-small cell lung cancer, hepatitis B, and autoimmune disorders including systemic lupus erythematosus and primary Sjögren’s disease.

• Testing new immunotherapy combinations in lung cancer and head and neck cancer
• Exploring better control of chronic hepatitis B
• Evaluating treatments for autoimmune and inflammatory diseases

These studies aim to improve disease control while also reducing the burden of long-term immune-related complications.

The site also contributes to research in digestive system diseases and neoplasms, with a strong emphasis on colorectal cancer, hepatocellular carcinoma, and pancreatic adenocarcinoma. These trials are designed to improve survival, reduce recurrence, and refine treatment choices for patients with complex gastrointestinal cancers.

• Evaluating new treatment strategies for colon cancer and colorectal metastases
• Studying approaches for liver cancer to reduce recurrence after local or surgical treatment
• Assessing therapies for pancreatic cancer in the perioperative setting

This research reflects a broad commitment to improving outcomes in advanced and high-risk gastrointestinal malignancies.

Beyond the major disease groups, the portfolio includes nervous system diseases, migraine, and selected musculoskeletal and eye-related conditions. Trials in these areas are generally focused on symptom control, disease modification, and better quality of life.

• Studying new options for migraine prevention
• Evaluating therapies for autoimmune conditions affecting the nervous system and joints
• Exploring supportive approaches for complex, chronic symptoms

At Hospital Universitario De Badajoz, these studies add depth to a research program that spans both common and highly specialized medical needs.